Here's how you can help your patients

About 70% to 80% of patients receiving chemotherapy experience chemotherapy-induced nausea and vomiting (CINV) if it's not properly prevented. In fact, patient surveys consistently rank nausea and vomiting as 2 of the worst side effects from treatment. How do you know if your patients are experiencing CINV? One study showed that incidence and impact of chemotherapy side effects on patients can be underestimated by healthcare providers, especially in the days following treatment.1

Why don't patients receiving chemotherapy share information about how they are feeling? Many people believe that nausea is a sign that their treatment is working. They worry that if they tell their healthcare team about feeling sick, they might have to receive a less effective dose to fight their cancer. The irony is that cancer patients don’t have to be sick from chemotherapy—not right after nor the days following chemotherapy. With diet and lifestyle changes and antinausea medications, patients can avoid the nausea and vomiting that often follows chemotherapy. Preventing CINV can help patients avoid the ups and downs of chemotherapy to make it through their course of treatment.

As a nurse, you are a key link to education for your patients and their families. The Stay Strong Patient Support program provides materials that will support your efforts. You can start by initiating a conversation with them before they start treatment, discussing risk factors and possible ways to avoid CINV. You may also want to encourage them to create a list of questions to discuss during their appointment. To make it easier, they can use a worksheet called Ask your doctor, which can be downloaded for their use. Or suggest they try out the "I felt" calendar or the "I felt" checklist that will help them talk to their treatment team about how they're feeling the week after chemotherapy.

Your role is critical in your patients' chemotherapy experience. ALOXI® is here to help you.

A nurse is a teacher, too

As early as 1973, the American Hospital Association (AHA) formally recognized the importance of providing information to patients and families so they could make informed decisions. In its brochure, “The Patient Care Partnership,” the AHA outlines the need for discussing medically appropriate treatment choices and encourages patients to tell their caregivers if they need more information.

Many oncology healthcare providers not only supply education for patients with cancer and their caregivers, but also access to support programs that can help fill in the gaps. You can find educational tools about managing chemotherapy-induced nausea and vomiting (CINV) with the Stay Strong Patient Support program, but this Web site also links you up with other online resources for many other aspects of cancer care.

The dual role of clinical care provider and educator is a critical one to cancer patients and their families. Good resources make it easier.

References

1. Grunberg SM, Deuson RR, Mavros P, et al. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics. Cancer. 2004;100:2261-2268.

2. American Hospital Association. The Patient Care Partnership. 2003. http://www.aha.org/aha/issues/Communicating-With-Patients/pt-care-partnership.html. Accessed August 23, 2007.


ALOXI (palonosetron HCl) injection 0.25 mg is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy, and acute nausea and vomiting associated with initial and repeat courses of highly emetogenic chemotherapy.

ALOXI is contraindicated in patients known to have hypersensitivity to the drug or any of its components. It should be administered with caution in patients who have or may develop prolongation of cardiac conduction intervals, particularly QTc. Most commonly reported adverse reactions include headache (9%) and constipation (5%).

ALOXI is available by prescription only. Please see the important product information for ALOXI for more information.

This site does not contain everything that is known about ALOXI. If you would like to know more, talk to your healthcare professional.